• home1
  • home4
  • home5
  • home1
  • home5
  • home2
Bionest Partners is unique among medical business strategy consultants, in developing creative strategies and actionable implementation plans.

We work to create competitive advantage for our clients by developing innovative and differentiated strategies at the corporate, portfolio and brand levels of medical and life science businesses. We also provide valuation and due diligence services to companies, investors and private equity.

We combine deep understanding of the science and technology underpinning our clients' products with strong commercial insights. Our approach is highly participative and we work closely with our clients to ensure that our processes and findings are fully integrated into client teams.

Our staff and clients are based on three continents, enabling us to bring global insights and recommendations to complex issues.


Bionest Partners leadership will be at the 2015 ASCO Annual Meeting, taking place in Chicago from May 29 to June 2.

If you would like to arrange a meeting, please contact us.


IN VIVO December 2014
IMMUNOTHERAPY: Big Pharma's Seductive Embrace

IN VIVO August 2014
WHEN ILLUMINA BUYS ROCHE: The Dawning of the Era of Diagnostics Dominance